BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27578187)

  • 1. Relation between safe use of medicines and Clinical Pharmacy Services at Pediatric Intensive Care Units.
    Okumura LM; Silva DM; Comarella L
    Rev Paul Pediatr; 2016 Dec; 34(4):397-402. PubMed ID: 27578187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of drug-related problems in pediatric ward of Zewditu Memorial Referral Hospital, Addis Ababa, Ethiopia.
    Birarra MK; Heye TB; Shibeshi W
    Int J Clin Pharm; 2017 Oct; 39(5):1039-1046. PubMed ID: 28689305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
    Malfará M; Pernassi M; Aragon D; Carlotti A
    Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-alert medications in the pediatric intensive care unit.
    Franke HA; Woods DM; Holl JL
    Pediatr Crit Care Med; 2009 Jan; 10(1):85-90. PubMed ID: 19057440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the ability of the Drug-Associated Risk Tool (DART) questionnaire to stratify hospitalised older patients according to their risk of drug-related problems: a cross-sectional validation study.
    Stämpfli D; Boeni F; Gerber A; Bättig VAD; Weidmann R; Hersberger KE; Lampert ML
    BMJ Open; 2018 Jun; 8(6):e021284. PubMed ID: 29950469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.
    Albayrak A; Başgut B; Bıkmaz GA; Karahalil B
    BMC Health Serv Res; 2022 Jan; 22(1):79. PubMed ID: 35033079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance.
    Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
    BMC Pediatr; 2019 Apr; 19(1):134. PubMed ID: 31027487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil.
    Leopoldino RD; Santos MT; Costa TX; Martins RR; Oliveira AG
    BMJ Open; 2019 Jul; 9(7):e024377. PubMed ID: 31296505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacy interventions in intensive care unit patients.
    Chiang LH; Huang YL; Tsai TC
    J Clin Pharm Ther; 2021 Feb; 46(1):128-133. PubMed ID: 32949428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Justifying a pediatric critical-care satellite pharmacy by medication-error reporting.
    Tisdale JE
    Am J Hosp Pharm; 1986 Feb; 43(2):368-71. PubMed ID: 3953597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected adverse drug reactions reported for Brazilian children: cross-sectional study.
    Lima EDC; Matos GC; Vieira JML; Gonçalves ICDCR; Cabral LM; Turner MA
    J Pediatr (Rio J); 2019; 95(6):682-688. PubMed ID: 30030984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Problemas relacionados con medicamentos que causan ingresos por urgencias en un hospital de alta complejidad.
    Calvo-Salazar RA; David M; Zapata-Mesa MI; Rodríguez-Naranjo CM; Valencia-Acosta NY
    Farm Hosp; 2018 Nov; 42(6):228-233. PubMed ID: 30381042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
    Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
    Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescription of drugs not appropriate for children in a Pediatric Intensive Care Unit].
    Carvalho PR; Carvalho CG; Alievi PT; Martinbiancho J; Trotta EA
    J Pediatr (Rio J); 2003; 79(5):397-402. PubMed ID: 14557839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of an Established Pharmaceutical Care Pathway on Drug Related Problems in an Intensive Care Unit.
    Toukhy A; Fayed S; Sabry N; Shawki M
    Am J Med Sci; 2021 Aug; 362(2):143-153. PubMed ID: 33745978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the potential impact of hospital ward-based pharmacy interns on drug safety.
    Schorr SG; Eickhoff C; Feldt S; Hohmann C; Schulz M
    Pharmazie; 2014 Apr; 69(4):316-20. PubMed ID: 24791599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Stay Unit and Emergency Department: Pharmacotherapeutic Interventions and Its Impact.
    Romero-Ventosa EY; Pérez-Landeiro A; Leboreiro-Enríquez B; Rubianes-González M; Lamas-Domínguez P; Pineiro-Corrales G
    Am J Ther; 2016; 23(6):e1307-e1314. PubMed ID: 26938748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echocardiography in PICU: when the heart sees what is invisible to the eye.
    Rabah F; Al-Senaidi K; Beshlawi I; Alnair A; Abdelmogheth AA
    J Pediatr (Rio J); 2016; 92(1):96-100. PubMed ID: 26569341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Acute Kidney Injury Defined by the Pediatric Risk, Injury, Failure, Loss, End-Stage Renal Disease Score on the Clinical Course of PICU Patients.
    Cabral FC; Ramos Garcia PC; Mattiello R; Dresser D; Fiori HH; Korb C; Dalcin TC; Piva JP
    Pediatr Crit Care Med; 2015 Oct; 16(8):e275-82. PubMed ID: 26252433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPICC study: evaluation of pharmaceutical intervention in cancer care.
    Vantard N; Ranchon F; Schwiertz V; Gourc C; Gauthier N; Guedat MG; He S; Kiouris E; Alloux C; You B; Souquet PJ; Freyer G; Salles G; Trillet-Lenoir V; Rioufol C
    J Clin Pharm Ther; 2015 Apr; 40(2):196-203. PubMed ID: 25594148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.